Constellation Pharmaceuticals Inc (CNST)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

215 FIRST STREET CAMBRIDGE, MA 02142

Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The Company discovers and develops molecule therapeutics for the treatment of cancer, inflammatory, and immunologic disorders. Constellation Pharmaceuticals serves patients worldwide.

Data as of 2020-09-12
Market Cap1.038 Billion Shares Outstanding47.5 Million Avg 30-day Volume490.086 Thousand
P/E Ratio Dividend Yield EPS-2.79
Price/Sales Price cash flow ratio Price free cash flow ratio-12.4
Book Value9.94 Price to Tangible Book2.19 Alpha0.09
Short Interest Ratio % Short Interest to Float R-squared0.082053
BETA2.88735 52-week High/Low59.4899 / 6.01 Stddev0.589727
View SEC Filings from CNST instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 9 12 -25.0% 2 (0.13%) 5 (0.32%) -60.0%
Funds Holding: 133 100 33.0% 50 (3.26%) 35 (2.24%) 42.86%
13F shares: 48.149 Million 39 Million 23.46% 20.566 Million 16.257 Million 26.51%
% Ownership 93.2517 43.2958 38.8708 11.38%
New Positions: 45 23 95.65% 22 7 214.29%
Increased Positions 57 43 32.56% 18 12 50.0%
Closed Positions 12 24 -50.0% 7 15 -53.33%
Reduced Positions 18 26 -30.77% 5 11 -54.55%
Total Calls 893.814 Thousand 64.509 Thousand 1285.56% 585.8 Thousand 62.1 Thousand 843.32%
Total Puts 62.705 Thousand 15.31 Thousand 309.57% 3 Thousand 8.4 Thousand -64.29%
PUT/CALL Ratio 0.07 0.24 -70.83% 0.01 0.14 -92.86%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CNST (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CNST BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUMPHREY JEFFREY CHIEF MEDICAL OFFICER

0 2020-07-07 2

REEVE EMMA CHIEF FINANCIAL OFFICER

0 2020-06-08 10

HOERTER STEVEN L.

0 2020-06-04 1

GOLDSMITH MARK A

0 2020-06-04 4

AUDIA JAMES E

0 2020-06-04 6

TREHU ELIZABETH

0 2020-06-04 1

BRAUNSTEIN SCOTT

0 2020-06-04 1

SENDEROWICZ ADRIAN CHIEF MEDICAL OFFICER

15,884 2020-05-12 3

RAYTHATHA JIGAR SEE REMARKS

14,961 2020-05-11 3

TROJER PATRICK CHIEF SCIENTIFIC OFFICER

0 2020-05-06 5

VALENTINE KAREN SEE REMARKS

0 2020-05-05 10

LEVY RICHARD S

  • Director
0 2020-04-03 2

COLUMN GROUP L P

COLUMN GROUP GP, LP

PONOI CAPITAL, LP

PONOI MANAGEMENT, LLC

PONOI CAPITAL II, LP

PONOI II MANAGEMENT, LLC

KUTZKEY TIM

GOEDDEL DAVID V

SVENNILSON PETER

  • 10% Owner
  • GENERAL PARTNER GENERAL PARTNERMANAGING PARTNERMANAGING PARTNERMANAGING PARTNER
6,210,531 2020-03-19 1

COLUMN GROUP L P

COLUMN GROUP III, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III GP, LP

  • 10% Owner
  • GENERAL PARTNER
6,210,531 2020-03-19 2

COLUMN GROUP III, LP

COLUMN GROUP III-A, LP

COLUMN GROUP III GP, LP

  • 10% Owner
  • GENERAL PARTNER
36,135 2020-03-19 1

EVNIN ANTHONY B

  • Director
5,742,765 2019-12-13 2

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VHCP CO-INVESTMENT HOLDINGS III, LLC

VHCP MANAGEMENT III, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
4,016,873 2019-12-13 2

REGENTS OF THE UNIVERSITY OF CALIFORNIA

2,110,290 2019-11-08 2

TEPPER ROBERT I

  • Director
  • 10% Owner
0 2019-06-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments